Samuel M. Shaolian

Mr. Samuel M. Shaolian has more than 30 years of experience in the design, development and management of biomedical devices and companies. Prior to founding Valcare Medical, Mr. Shaolian founded and served as CTO of Micardia Corporation, developing novel mitral repair systems.

In 2000, he founded Vettelink Corporation developing a minimally invasive instrumentation and method for spinal fusion Vertelink Corporation was acquired by Medtronic in 2003. Mr. Shaolian also served as Vice President of R&D for Endologix, designing and developing products for the treatment of aortic aneurysms.

Mr. Shaolian is an inventor and co-inventor, holding over 60 issued U.S. patents. He holds a B.Sc in Mechanical Engineering and a M.Sc in Biomedical Engineering from Tel Aviv University, Israel.